207 related articles for article (PubMed ID: 12654343)
1. Mu opioid receptor signaling in morphine sensitization.
Viganò D; Rubino T; Di Chiara G; Ascari I; Massi P; Parolaro D
Neuroscience; 2003; 117(4):921-9. PubMed ID: 12654343
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
Viganò D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
[TBL] [Abstract][Full Text] [Related]
4. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
[TBL] [Abstract][Full Text] [Related]
5. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
[TBL] [Abstract][Full Text] [Related]
7. Role of gonadal hormones on mu-opioid-stimulated [³⁵S]GTPγS binding and morphine-mediated antinociception in male and female Sprague-Dawley rats.
Peckham EM; Graves SM; Jutkiewicz E; Becker JB; Traynor JR
Psychopharmacology (Berl); 2011 Dec; 218(3):483-92. PubMed ID: 21607564
[TBL] [Abstract][Full Text] [Related]
8. Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.
Talbot JN; Happe HK; Murrin LC
J Pharmacol Exp Ther; 2005 Aug; 314(2):596-602. PubMed ID: 15860573
[TBL] [Abstract][Full Text] [Related]
9. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
10. Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate.
Daunais JB; Letchworth SR; Sim-Selley LJ; Smith HR; Childers SR; Porrino LJ
J Comp Neurol; 2001 May; 433(4):471-85. PubMed ID: 11304712
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
12. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain.
Sim-Selley LJ; Daunais JB; Porrino LJ; Childers SR
Neuroscience; 1999; 94(2):651-62. PubMed ID: 10579225
[TBL] [Abstract][Full Text] [Related]
13. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.
Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR
Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350
[TBL] [Abstract][Full Text] [Related]
14. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
15. Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G.
Wang YJ; Huang P; Blendy JA; Liu-Chen LY
Addict Biol; 2014 May; 19(3):354-61. PubMed ID: 22862850
[TBL] [Abstract][Full Text] [Related]
16. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
17. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.
Maher CE; Selley DE; Childers SR
Biochem Pharmacol; 2000 Jun; 59(11):1395-401. PubMed ID: 10751548
[TBL] [Abstract][Full Text] [Related]
18. Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain.
Kirschke C; Schadrack J; Zieglgänsberger W; Spanagel R
Eur J Pharmacol; 2002 Jun; 446(1-3):43-51. PubMed ID: 12098584
[TBL] [Abstract][Full Text] [Related]
19. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
Madia PA; Navani DM; Yoburn BC
Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
[TBL] [Abstract][Full Text] [Related]
20. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
